-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael J. Fine, MD

Articles by Michael J. Fine, MD

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

ByRobert Zivadinov, MD, PhD,Michael J. Fine, MD,Krishna R. Patel, PharmD, RPh,Neil Minkoff, MD

January 25th 2022

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

ByJeffrey L. Cummings, MD, ScD,Michael J. Fine, MD,Igor D. Grachev, MD, PhD,C. Rick Jarecke, PharmD,Meridith K. Johnson, MSc,Phillip H. Kuo, MD, PhD,Joyce A. Oberdorf,Michael Rezak, MD, PhD,Da

March 24th 2014

Cost of Care for Malignant and Benign Renal Masses

ByAviva G. Asnis-Alibozek, PA-C,Michael J. Fine, MD,Paul Russo, MD,Trent McLaughlin, BSc(Pharm), PhD,Eileen M. Farrelly, MPH,Norman LaFrance, MD,William Lowrance, MD, MPH

August 12th 2013

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

Latest Updated Articles

Trending on AJMC

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Kazia Therapeutics Discusses Shift for Paxalisib Into Triple-Negative Breast Cancer

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD